Table 1.
Outcome at 12 months N (%) |
|||||
---|---|---|---|---|---|
No lesion | CIN 1 | CIN 2 | CIN 3 | ||
| |||||
Study entry | |||||
CIN 1 | 100 (69.9) | 36 (25.2) | 5 (3.5) | 2 (1.4) | 143 |
CIN 2 | 34 (54.0) | 14 (22.2) | 12 (19.0) | 3 (4.8) | 63 |
| |||||
Total | 134 (65.0) | 50 (24.3) | 17 (8.3) | 5 (2.4) | 206 |
Outcome at 12 months N (%) |
|||||
---|---|---|---|---|---|
No lesion | CIN 1 | CIN 2 | CIN 3 | ||
| |||||
Study entry | |||||
CIN 1 | 100 (69.9) | 36 (25.2) | 5 (3.5) | 2 (1.4) | 143 |
CIN 2 | 34 (54.0) | 14 (22.2) | 12 (19.0) | 3 (4.8) | 63 |
| |||||
Total | 134 (65.0) | 50 (24.3) | 17 (8.3) | 5 (2.4) | 206 |